 The stock price of Charles River Laboratories, a company that offers clinical laboratory, gene therapy, and cell therapy services for the pharmaceuticals industry, has seen a 13 rise over the last twenty-one trading days. The company recently completed the acquisition of Vigene Biosciences. 